Both sleep loss and pathogens can enhance brain inflammation, sleep, and sleep intensity as indicated by electroencephalogram delta (d) power. The pro-inflammatory cytokine interleukin-1 beta (IL-1b) is increased in the cortex after sleep deprivation (SD) and in response to the Gram-negative bacterial cell-wall component lipopolysaccharide (LPS), although the exact mechanisms governing these effects are unknown. The nucleotide-binding domain and leucine-rich repeat protein-3 (NLRP3) inflammasome protein complex forms in response to changes in the local environment and, in turn, activates caspase-1 to convert IL-1b into its active form. SD enhances the cortical expression of the somnogenic cytokine IL1b, although the underlying mechanism is, as yet, unidentified. Using NLRP3-gene knockout (KO) mice, we provide evidence that NLRP3 inflammasome activation is a crucial mechanism for the downstream pathway leading to increased IL-1b-enhanced sleep. NLRP3 KO mice exhibited reduced non-rapid eye movement (NREM) sleep during the light period. We also found that sleep amount and intensity (d activity) were drastically attenuated in NLRP3 KO mice following SD (homeostatic sleep response), as well as after LPS administration, although they were enhanced by central administration of IL-1b. NLRP3, ASC, and IL1b mRNA, IL-1b protein, and caspase-1 activity were greater in the somatosensory cortex at the end of the wake-active period when sleep propensity was high and after SD in wild-type but not NLRP3 KO mice. Thus, our novel and converging findings suggest that the activation of the NLRP3 inflammasome can modulate sleep induced by both increased wakefulness and a bacterial component in the brain.
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Introduction
Many brain areas-including the cortex, thalamus, ventral lateral preoptic area, median preoptic nucleus, basal forebrain, and brainstem-are known to modulate NREM sleep (Brown et al., 2012; Szymusiak, 2010; Saper et al., 2010) . In particular, somatosensory cortex activity modulates sleep and the electroencephalogram (EEG) (Timofeev, 2013) . Increased wakefulness, such as that occurring during sleep deprivation (SD), enhances the expression of pro-inflammatory molecules in the somatosensory cortex including interleukin-1 beta (IL-1b) (Zielinski and Krueger, 2011; Imeri and Opp, 2009 ). IL-1b expression and protein levels in the cortex exhibit diurnal variations that coincide with sleep propensity (Krueger et al., 2010; Taishi et al., 1998 Taishi et al., , 2012 . IL-1b applied centrally or to the periphery enhances NREM sleep in rabbits, rats, and mice (Zielinski and Krueger, 2011; Obal et al., 1995; Olivadoti and Opp, 2008; Toth and Opp, 2001) , although higher dosages can inhibit sleep (Opp et al., 1991) . Nevertheless, the exact mechanisms for cortical IL-1b regulation of sleep are unknown.
EEG NREM sleep delta (d) power spectra (0.5-4 Hz frequency range; also referred to as slow-wave activity) is often used as an indicator of sleep need after acute SD (Davis et al., 2011) . NREM sleep d power is, in part, regulated by a thalamo-cortico-thalamo loop (Steriade, 2006) . While the exact mechanism(s) responsible for the NREM sleep d power are unknown, pro-inflammatory molecules tend to enhance it (Zielinski and Krueger, 2011; Imeri and Opp, 2009) , for example, IL-1b enhances NREM sleep d power in
